Provexis

PXS.L

Tags: GB Healthcare Drug Manufacturers - Specialty & Generic

Provexis plc Price (PXS.L)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

2,217,821,523

(0.0459)%

Market Cap of Provexis (PXS.L)

Market cap:

As of , PXS.L has a market cap of . This makes PXS.L the 1058th most valuable company in the GB by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Community Sentiment 0 votes

↑ 0% ↓ 0%

Description

Provexis plc, together with its subsidiaries, develops, licenses, and markets functional foods, medical foods, and dietary supplements worldwide. Its products include Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke. The company's syrup and powder versions of Fruitflow are used in foods, beverages, and dietary supplement formats. It also offers Fruitflow + Omega-3, a supplement in capsule form that supports healthy blood flow and normal h... Read More

Sector: Healthcare

Previous Close Fetching Data...
Range $0.45-0.8
Market Cap 11.49M
Enterprise Value No Data
Avg Volume Fetching Data...
P/E Ratio Fetching Data...
Dividend Yield Fetching Data...

Industry: Drug Manufacturers - Specialty & Generic

ceo: Mr. Ian Ford BA (Hons) ACA, F.C.A.
IPO Date: June, 28, 2004
Country: GB
Currency: GBp
Headquaters: No Data
Employees: 2

- Revenue from each product or segment:

Product or Segment	Value:	% - Total	Last 3Y:

- Revenue by Region

Product or Segment	Value:	% - Total	Last 3Y: